Syntara Limited has released a press release.
Appendix 4C Quarterly Cash Flow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Syntara
- Response to ASX Aware Query
- PXS Collaborators Receive Government Grants of $1.4m
- Share Purchase Plan
- Security Purchase Plan
- FDA Clears PXS Cancer Drug for Phase 2 Liver Cancer Study
Later from Syntara
- Clarification Announcement
- Aptar Pharma Pays PXS Us$5m to Acquire Orbital Technology
- PXS to Receive Stg2.9m from Parkinsons UK for New Trial
- PXS Releases Promising Interim Data from Skin Scarring Study
- Investor Presentation
Follow Syntara into a list and get an email when it puts out news.
Follow Syntara